Oakworth Capital’s Johnson & Johnson JNJ Stock Holding History

Oakworth Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.68M	Sell	18,417 -26	-0.1%	-$6.06K	0.22%	39
2026 Q1	$4.51M	Sell	18,443 -484	-3%	-$113K	0.24%	36
2025 Q4	$3.92M	Buy	18,927 +162	+0.9%	+$32K	0.21%	38
2025 Q3	$3.48M	Sell	18,765 -32	-0.2%	-$5.48K	0.2%	40
2025 Q2	$2.87M	Sell	18,797 -92	-0.5%	-$14.1K	0.19%	40
2025 Q1	$3.13M	Buy	18,889 +558	+3%	+$87.3K	0.22%	38
2024 Q4	$2.65M	Sell	18,331 -888	-5%	-$138K	0.18%	41
2024 Q3	$3.11M	Sell	19,219 -1,728	-8%	-$275K	0.22%	37
2024 Q2	$3.06M	Sell	20,947 -833	-4%	-$124K	0.22%	37
2024 Q1	$3.45M	Buy	21,780 +2,130	+11%	+$339K	0.26%	35
2023 Q4	$3.08M	Sell	19,650 -473	-2%	-$72.5K	0.25%	32
2023 Q3	$3.13M	Sell	20,123 -517	-3%	-$85.3K	0.28%	29
2023 Q2	$3.42M	Sell	20,640 -328	-2%	-$52.9K	0.29%	27
2023 Q1	$3.25M	Sell	20,968 -326	-2%	-$52.6K	0.29%	27
2022 Q4	$3.76M	Sell	21,294 -69	-0.3%	-$11.9K	0.36%	23
2022 Q3	$3.49M	Buy	21,363 +63	+0.3%	+$10.7K	0.39%	25
2022 Q2	$3.78M	Sell	21,300 -132	-0.6%	-$23.5K	0.38%	27
2022 Q1	$3.8M	Buy	21,432 +990	+5%	+$168K	0.33%	28
2021 Q4	$3.5M	Sell	20,442 -101	-0.5%	-$16.5K	0.3%	27
2021 Q3	$3.32M	Buy	20,543 +554	+3%	+$94.5K	0.32%	26
2021 Q2	$3.29M	Sell	19,989 -382	-2%	-$63.2K	0.33%	23
2021 Q1	$3.35M	Buy	20,371 +953	+5%	+$154K	0.38%	24
2020 Q4	$3.06M	Buy	19,418 +255	+1%	+$37.6K	0.4%	23
2020 Q3	$2.85M	Buy	19,163 +320	+2%	+$47.4K	0.46%	24
2020 Q2	$2.65M	Buy	18,843 +401	+2%	+$58.4K	0.48%	24
2020 Q1	$2.42M	Buy	18,442 +1,277	+7%	+$181K	0.57%	22
2019 Q4	$2.49M	Buy	17,165 +725	+4%	+$98.3K	0.44%	26
2019 Q3	$2.13M	Sell	16,440 -4,043	-20%	-$533K	0.41%	27
2019 Q2	$2.85M	Buy	20,483 +296	+1%	+$41K	0.54%	26
2019 Q1	$2.82M	Buy	20,187 +450	+2%	+$60.3K	0.58%	25
2018 Q4	$2.55M	Sell	19,737 -3,582	-15%	-$500K	0.58%	24
2018 Q3	$3.22M	Buy	23,319 +511	+2%	+$67.9K	0.64%	23
2018 Q2	$2.77M	Buy	22,808 +1,825	+9%	+$228K	0.57%	23
2018 Q1	$2.65M	Sell	20,983 -1,056	-5%	-$143K	0.63%	21
2017 Q4	$3.07M	Sell	22,039 -2,188	-9%	-$305K	0.72%	21
2017 Q3	$3.21M	Buy	24,227 +580	+2%	+$76.9K	0.82%	22
2017 Q2	$3.13M	Buy	23,647 +47	+0.2%	+$6K	0.86%	21
2017 Q1	$2.94M	Buy	23,600 +403	+2%	+$48.1K	0.85%	21
2016 Q4	$2.58M	Buy	23,197 +3,641	+19%	+$421K	0.85%	22
2016 Q3	$2.31M	Sell	19,556 -3,206	-14%	-$389K	0.8%	21
2016 Q2	$2.56M	Buy	22,762 +13	+0.1%	+$1.48K	0.96%	20
2016 Q1	$2.46M	Buy	22,749 +2,393	+12%	+$248K	0.98%	20
2015 Q4	$2.09M	Buy	20,356 +12,194	+149%	+$1.23M	0.87%	18
2015 Q3	$762K	Hold	8,162	–	–	0.4%	31
2015 Q2	$818K	Sell	8,162 -2,500	-23%	-$250K	0.39%	33
2015 Q1	$1.06M	Hold	10,662	–	–	0.49%	28
2014 Q4	$1.11M	Buy	10,662 +2,520	+31%	+$266K	0.58%	27
2014 Q3	$845K	Hold	8,142	–	–	0.5%	27
2014 Q2	$852K	Hold	8,142	–	–	0.52%	27
2014 Q1	$800K	Buy	8,142 +2,426	+42%	+$225K	0.52%	26
2013 Q4	$524K	Buy	+5,716	New	+$527K	0.37%	29

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

PAM

PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Oakworth Capital's JNJ Position: Q2 2026 in Review

Oakworth Capital reduced its Johnson & Johnson (JNJ) stake by 0.14% in Q2 2026, selling an estimated $6.06K and leaving 18,417 shares worth $4.68M. The position accounts for 0.22% of the portfolio, ranked #39.

Oakworth Capital first reported a position in JNJ in Q4 2013 and has held it in 51 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Oakworth Capital held 18,417 shares of Johnson & Johnson worth $4.68M as of Q2 2026.
Oakworth Capital sold 26 Johnson & Johnson shares in Q2 2026, an estimated $6.06K.
Johnson & Johnson made up 0.22% of Oakworth Capital's portfolio in Q2 2026, its #39 holding.
Oakworth Capital first reported a position in Johnson & Johnson in Q4 2013 and has held it in 51 quarters since.
1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.